Article info
PDFCoronary artery disease
Original article
Clinical benefit from pharmacological elevation of high-density lipoprotein cholesterol: meta-regression analysis
- Correspondence to Dr Florence Hourcade-Potelleret, Novartis Pharma AG, Postfach, Basel CH-4002, Switzerland; florence.hourcade-potelleret{at}novartis.com
Citation
Clinical benefit from pharmacological elevation of high-density lipoprotein cholesterol: meta-regression analysis
Publication history
- Received August 22, 2014
- Revised February 27, 2015
- Accepted March 14, 2015
- First published April 14, 2015.
Online issue publication
October 25, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions